263 related articles for article (PubMed ID: 26342331)
1. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
[TBL] [Abstract][Full Text] [Related]
2. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
[TBL] [Abstract][Full Text] [Related]
4. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Campagna F; Montali A; Baroni MG; Maria AT; Ricci G; Antonini R; Verna R; Arca M
Metabolism; 2002 Oct; 51(10):1298-305. PubMed ID: 12370850
[TBL] [Abstract][Full Text] [Related]
5. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
[TBL] [Abstract][Full Text] [Related]
6. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
Deeb SS; Nevin DN; Iwasaki L; Brunzell JD
Hum Mutat; 1996; 8(4):319-25. PubMed ID: 8956036
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia.
Gagné E; Genest J; Zhang H; Clarke LA; Hayden MR
Arterioscler Thromb; 1994 Aug; 14(8):1250-7. PubMed ID: 8049185
[TBL] [Abstract][Full Text] [Related]
8. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity.
Nevin DN; Brunzell JD; Deeb SS
Arterioscler Thromb; 1994 Jun; 14(6):869-73. PubMed ID: 8199176
[TBL] [Abstract][Full Text] [Related]
9. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
Yang WS; Nevin DN; Peng R; Brunzell JD; Deeb SS
Proc Natl Acad Sci U S A; 1995 May; 92(10):4462-6. PubMed ID: 7753827
[TBL] [Abstract][Full Text] [Related]
10. Familial combined hyperlipidemia and abnormal lipoprotein lipase.
Babirak SP; Brown BG; Brunzell JD
Arterioscler Thromb; 1992 Oct; 12(10):1176-83. PubMed ID: 1390589
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.
Solanas-Barca M; de Castro-Orós I; Mateo-Gallego R; Cofán M; Plana N; Puzo J; Burillo E; Martín-Fuentes P; Ros E; Masana L; Pocoví M; Civeira F; Cenarro A
Atherosclerosis; 2012 Jun; 222(2):449-55. PubMed ID: 22481068
[TBL] [Abstract][Full Text] [Related]
12. Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Hoffer MJ; Bredie SJ; Snieder H; Reymer PW; Demacker PN; Havekes LM; Boomsma DI; Stalenhoef AF; Frants RR; Kastelein JJ
Atherosclerosis; 1998 May; 138(1):91-9. PubMed ID: 9678774
[TBL] [Abstract][Full Text] [Related]
13. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
14. A novel variant in LPL gene is associated with familial combined hyperlipidemia.
Taghizadeh E; Ghayour-Mobarhan M; Ferns GA; Pasdar A
Biofactors; 2020 Jan; 46(1):94-99. PubMed ID: 31599081
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
[TBL] [Abstract][Full Text] [Related]
16. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
Pajukanta P; Porkka KV; Antikainen M; Taskinen MR; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari AT; Syvänen AC; Viikari JS; Ehnholm C; Peltonen L
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):841-50. PubMed ID: 9157946
[TBL] [Abstract][Full Text] [Related]
17. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Reynisdottir S; Angelin B; Langin D; Lithell H; Eriksson M; Holm C; Arner P
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2287-92. PubMed ID: 9351402
[TBL] [Abstract][Full Text] [Related]
19. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
[TBL] [Abstract][Full Text] [Related]
20. The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.
Wung SF; Kulkarni MV; Pullinger CR; Malloy MJ; Kane JP; Aouizerat BE
Lipids Health Dis; 2006 Jul; 5():19. PubMed ID: 16822320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
